RE: R M. P45?6 May 2021 15:18
Mr Costs, "Synairgen is a drug discovery and development company". Any profit is a bonus. Profit IS NOT the company's priority, and perhaps that is what many investors have overlooked. I believe that only in a single 12 month period over 17 years has it made a profit from its "drug discovery and development" operations.
While the current environment offers up a good possibility for profit there is no reason to think the BoD will approach this possibility any differently (from a commercial perspective) than they have over the last 17 years. As they continually espouse "data, data, data" is king.